| Literature DB >> 27980672 |
Zaigao Tan1,2, Jing Chen1,2, Xueli Zhang1,2.
Abstract
BACKGROUND: Succinate biosynthesis of Escherichia coli is reducing equivalent-dependent and the EMP pathway serves as the primary reducing equivalent source under anaerobic condition. Compared with EMP, pentose phosphate pathway (PPP) is reducing equivalent-conserving but suffers from low efficacy. In this study, the ribosome binding site library and modified multivariate modular metabolic engineering (MMME) approaches are employed to overcome the low efficacy of PPP and thus increase succinate production.Entities:
Keywords: Escherichia coli; Multivariate modular metabolic engineering (MMME); Pentose phosphate pathway (PPP); Reducing equivalent; Ribosome binding site library (RBSL); Succinate
Year: 2016 PMID: 27980672 PMCID: PMC5134279 DOI: 10.1186/s13068-016-0675-y
Source DB: PubMed Journal: Biotechnol Biofuels ISSN: 1754-6834 Impact factor: 6.040
Fig. 1Production of succinate anaerobically in E. coli. Through EMP pathway, 14.3 mol glucose produces 28.6 mol PEP and 28.6 mol NADH (catalyzed by gapA). Through PPP, 85.7 mol glucose produces 142.8 mol PEP, 171.4 mol NADPH (catalyzed by zwf and gnd), 142.8 mol NADH (catalyzed by gapA), and 85.7 mol CO2. Through combinational utilization of EMP and PPP, 100 mol glucose produces 171.4 mol PEP, 171.4 mol NADH, 171.4 mol NADPH, and 85.7 mol CO2. The formed 171.4 mol NADPH can be converted into 171.4 mol NADH by increased expression of SthA. In Suc-T110, phosphoenolpyruvate carboxykinase (pck) is the predominant PEP carboxylase and most of PEP flux goes into the reductive TCA cycle (mdh-fumB-frd) for succinate biosynthesis [25]. Finally, 100 mol glucose coupled with 85.7 mol CO2 can produce 171.4 mol succinate, by which it achieves the theoretical maximum yield of 1.71 mol/mol glucose. EMP, Embden–Meyerhof–Parnas (glycolysis) pathway; PPP, pentose phosphate pathway; 6-P-Glc, glucose-6-phosphate; 6-P-Fru, fructose-6-phosphate; FBP, fructose-1,6-bisphosphate; 1,6-2P-Fru, 1,6-bisphosphate fructose; G3P, glyceraldehyde-3-phosphate; DHAP, dihydroxyacetone phosphate; 1,3-BPG, 1,3-bisphosphoglycerate; PEP, phosphoenolpyruvate; Pyr, pyruvate; OAA, oxaloacetate; 6-P-Glc-I, 6-phosphoglucono-δ-lactone; Glc6P, 6-phosphogluconate; Ru5P, ribulose-5-phosphate; R5P, ribose-5-phosphate; X5P, xylulose-5-phosphate; S7P, sedoheptulose-7-phosphate; E4P, erythrose-4-phosphate; F6P, fructose-6-phosphate; Mal, malate; Fum, fumarate; pgi, phosphoglucose isomerase; zwf, glucose-6-phosphate dehydrogenase; pgl, 6-phosphogluconolactonase; gnd, 6-phosphogluconate dehydrogenase; rpiA, ribose-5-phosphate isomerase; rpe, ribulose-5-phosphate-3-epimerase; tktA, transketolase; talB, transaldolase; gapA, glyceraldehyde 3-phosphate dehydrogenase; ppc, phosphoenolpyruvate carboxylase; pck, phosphoenolpyruvate carboxykinase; maeA, NAD+-dependent malic enzyme; maeB, NADP+-dependent malic enzyme; mdh, malate dehydrogenase; fumB, fumarase; frd, fumarate reductase; sthA, soluble pyridine nucleotide transhydrogenase; ADP, adenosine diphosphate; ATP, adenosine triphosphate; NAD+, oxidized nicotinamide adenine dinucleotide; NADH, reduced nicotinamide adenine dinucleotide; NADP+, oxidized nicotinamide adenine dinucleotide phosphate; NADPH, reduced nicotinamide adenine dinucleotide phosphate
Fig. 2Schematic of the construction of ribosome binding site library (RBSL) of PPP enzymes. The seven PPP enzymes locate dispersedly among E. coli MG1655 chromosome. A constitutive promoter M1-93 was initially used to replace native promoter of PPP enzymes. Next, seven degenerate nucleotides (RNNNNNN) were introduced into the RBS region of M1-93 promoter before ATG start codon to obtain the RBSL
Fig. 3Increased expression of PPP enzymes for succinate production. Relationship between the expression level (enzymatic activity) of each PPP enzyme and succinate production. Square symbol represents succinate titer and triangle symbol represents succinate yield. Values are the average of three biological replicates with error bars indicating one standard deviation. L, low expression level; M, medium expression level; H, high expression level
Fig. 4Modular engineering of PPP for succinate production. Effect of engineering a ZPG module, b RR module, and c TT module on succinate production. d Combinational utilization of optimized ZPG module (H-Zwf/M-Pgl/M-Gnd, labeled by 4-point star in a), optimized TT module (M-Tkt/H-Tal, labeled by 4-point star in c), and increased expression of SthA for succinate production. The final succinate yield in Suc-P02 is up to 1.61 mol/mol glucose, which increased by 44% over the starting strain Suc-T110 (~1.12 mol/mol). Values are the average of three biological replicates with error bars indicating one standard deviation. The 4-point star labels the best-performing succinate-producing strain during individual module engineering; the 5-point star indicates the strain with excessive expression of single module accompanied with significantly decreased succinate production. L, low expression level; M, medium expression level; H, high expression level
Fig. 5Alleviating metabolic imbalance via the MMME approach. Succinate titers of the starting strains with H-ZPG, H-RR, and H-TT are only 34, 106, and 296 mM, respectively. For H-ZPG, the M-RR/M-TT leads to a sevenfold increase of succinate to 237 mM. For H-RR, the M-ZPG intervention increases its titer by 148% to 263 mM, and following H-TT modification, it further increases by 22% to 321 mM. For H-TT, M-ZPG/M-RR finally increased succinate titer by 11% to 328 mM. Values are the average of three biological replicates with error bars indicating one standard deviation. L, low expression level; M, medium expression level; H, high expression level; MMME, modified multivariate modular metabolic engineering